MedPath
HSA Approval

YSP HYDROCORT CREAM 1% W/W

SIN11172P

YSP HYDROCORT CREAM 1% W/W

YSP HYDROCORT CREAM 1% W/W

September 22, 1999

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CREAM

**Dosage and Administration:** A small amount should be applied topically, twice daily. To be used as directed by the physician.

TOPICAL

Medical Information

**Indication(s):** Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

**Contraindication(s):** 1. Contraindicated in patients who have shown hypersensitivity to this drug. 2. Contraindicated in primary bacterial, viral and fungal diseases of the skin and secondarily infected eczemas or intertrigo.

D07AA02

hydrocortisone

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

HYDROCORTISONE ACETATE

10 mg/g

Documents

Package Inserts

YSP Hydrocort Cream PI.pdf

Approved: June 16, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

YSP HYDROCORT CREAM 1% W/W - HSA Approval | MedPath